Ashley Flynn Ward

Ashley Flynn Ward has a diverse work experience spanning multiple prestigious organizations. Ashley Flynn currently holds the position of Vice President Clinical Development at MacroGenics, Inc., starting in May 2022. Prior to this, they served as the Executive Director, Clinical Research at the same company from June 2021 to May 2022.

Before joining MacroGenics, Inc., Ashley worked at Foundation Medicine as the Senior Director, Clinical Development from February 2020 to May 2021.

Ashley's career also includes significant roles at the FDA, where they served as the Clinical Team Leader, Melanoma/Sarcoma Team in the Division of Oncology Products 2, Office of Hematology and Oncology Products, CDER. Ashley Flynn led disease-area internal research strategy and external collaborations, and served as the cross-disciplinary team lead for all INDs, NDAs, and BLAs in the melanoma and sarcoma space. Ashley Flynn also held the position of Acting Associate Director, Division of Oncology Products 2 and Medical Officer at the FDA.

Additionally, Ashley has prior experience as an Associate Medical Director and Assistant Medical Director at Oncology Exploratory Clinical Development, Genentech, where they led clinical science teams for novel oncology therapies and was responsible for clinical trial development, oversight, and data interpretation.

Ashley's earlier career includes roles at the University of California, San Francisco as an Assistant Professor, Pediatric Hematology/Oncology, Instructor, and Fellow in Pediatric Hematology/Oncology. Ashley Flynn also served as Chief Resident and Resident in Pediatrics at St. Louis Children's Hospital.

Overall, Ashley Flynn Ward has extensive experience in clinical development, research, and leadership roles in the pharmaceutical industry, as well as in academia.

Ashley Flynn Ward obtained a Bachelor of Arts degree in Biology from Swarthmore College, where they studied from 1994 to 1998. Following their undergraduate education, they pursued a medical degree and attended the Washington University School of Medicine in St. Louis from 1999 to 2003.

In terms of certifications, Ashley became Board Certified in General Pediatrics in October 2007. Later on, in March 2011, they obtained another certification in the field of Pediatric Hematology and Oncology. The institutions from which they received these certifications are undisclosed.